Leibman Financial Services’s Globus Medical GMED Stock Holding History

Leibman Financial Services’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.37M	Buy	+31,650	New	+$2.51M	1.64%	28

Other funds holding GMED

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $251M AUM 42.58% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Leibman Financial Services's GMED Position: Q3 2026 in Review

Leibman Financial Services opened a new position in Globus Medical (GMED) in Q3 2026: 31,650 shares worth $2.37M. The stake represents 1.64% of the portfolio and ranks #28 among its holdings.

49 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

Leibman Financial Services held 31,650 shares of Globus Medical worth $2.37M as of Q3 2026.
Globus Medical was a new Leibman Financial Services position in Q3 2026.
Globus Medical made up 1.64% of Leibman Financial Services's portfolio in Q3 2026, its #28 holding.
49 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Leibman Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.